Not recruitingISRCTN13406737
Combination of citalopram and nortriptyline in the treatment of moderate to severe major depression: a double-blind placebo-controlled trial
Research studyAges 18+Iran
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Iran
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Tehran University of Medical Sciences (Iran)
- Sponsor type
- University
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- Iran
- Age range
- Over 18 Years
- Official registry ID
- ISRCTN13406737
- Official title
Show the full official title
Combination of citalopram and nortriptyline in the treatment of moderate to severe major depression: a double-blind placebo-controlled trial
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Iran
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Tehran University of Medical Sciences (Iran), a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomised trial
Effectiveness of an emotion-focused behavioral treatment program for adults with multiple sclerosis
